Literature DB >> 27681251

Restenosis after percutaneous coronary intervention for coronary chronic total occlusion. The central role of an optimized immediate post-procedural angiographic result.

Karl Isaaz1, Antoine Gerbay2, Jérémy Terreaux2, Hazem Khamis2, Khalid Tammam2, Laure Richard2, Alexis Cerisier2, Michel Lamaud2, Antoine Da Costa2.   

Abstract

BACKGROUND: Factors of restenosis after percutaneous coronary intervention (PCI) for chronic total coronary occlusion (CTO) have not been fully explored. In particular, although the last ACC/AHA guidelines on PCI suggest that a minimum diameter stenosis of 10% with an optimal goal of as close to 0% as possible should be the new benchmark for lesions treated by stenting, angiographic success of PCI for CTO remains in the literature most often defined as a <30% residual diameter stenosis. Whether an optimized immediate post-PCI angiographic result (OAR) defined by a minimal diameter stenosis as close to 0% is associated with a lower restenosis rate in this subset of coronary lesions remains unknown.
METHODS: Therefore, we assessed by quantitative coronary analysis (QCA) both the immediate post-PCI and 6-month follow-up angiographic results of 170 successfully treated true CTO.
RESULTS: Post-PCI QCA immediate residual diameter stenosis was <30% in all 170 CTOs and OAR defined as a ≤10% residual stenosis was achieved in 133 (78%). Global binary restenosis rate was 21% in the 170 lesions. Restenosis rates were 46% and 14% in the non-OAR group and in the OAR group, respectively (p<0.0001). Multivariate analysis showed that a non-OAR, a younger age and a retrograde approach were independent factors of restenosis.
CONCLUSION: Thus, an optimized immediate angiographic result with a minimal diameter stenosis as close to 0% as possible appears to be associated with a lower rate of restenosis after CTO PCI.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Chronic total occlusion; Coronary occlusion; Drug-eluting stent; Percutaneous coronary intervention; Restenosis

Mesh:

Year:  2016        PMID: 27681251     DOI: 10.1016/j.ijcard.2016.09.028

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Impact of Angiographic Residual Stenosis on Clinical Outcomes After New-Generation Drug-Eluting Stents Implantation: Insights From a Pooled Analysis of the RESET and NEXT Trials.

Authors:  Hiroki Watanabe; Takeshi Morimoto; Hiroki Shiomi; Masahiro Natsuaki; Kazuya Kawai; Ken Kozuma; Keiichi Igarashi; Kazushige Kadota; Kengo Tanabe; Yoshihiro Morino; Kiyoshi Hibi; Takashi Akasaka; Mitsuru Abe; Satoru Suwa; Toshiya Muramatsu; Masakazu Kobayashi; Kazuoki Dai; Koichi Nakao; Yasuhiro Tarutani; Kenshi Fujii; Takeshi Kimura
Journal:  J Am Heart Assoc       Date:  2018-06-30       Impact factor: 5.501

2.  Clinical Implications of "Tailored" Antiplatelet Therapy in Patients With Chronic Total Occlusion.

Authors:  Maria Grazia De Gregorio; Rossella Marcucci; Angela Migliorini; Anna Maria Gori; Betti Giusti; Ruben Vergara; Rita Paniccia; Nazario Carrabba; Niccolò Marchionni; Renato Valenti
Journal:  J Am Heart Assoc       Date:  2020-02-11       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.